1. Metformin use is associated with reduced all-cause mortality in patients with chronic kidney disease, congestive heart failure, or chronic liver disease with hepatic impairment.
2. In this systemic review, fewer heart failure readmissions were observed in patients with CKD or CHF that were treated with metformin.
Evidence Rating Level: 1...